Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Escitalopram/Bupropion for Depression
NCT00296712Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram, bupropion in major depressive disorder (MDD), persistent depressive disorder (PDD), sponsored by New York State Psychiatric Institute. Started Feb 2005; status: completed.
02
Drugs
escitaloprambupropion
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00296712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296712.